Khiron Life Sciences Corp. (TSXV: KHRN) announced today the opening of Zerenia Clinics UK in London. This marks the first international clinic in Europe for the company.
The clinic is said to be of a hybrid model: while it has a digital clinic, it will also offer in-person appointments with its specialists. The firm also said that the clinic will initially focus on pain management before expanding its therapeutic portfolio to other areas.
The London clinic, which will be based in the Chelsea district, is the brand’s 15th location globally.
In October 2021, the cannabis firm saw its CFO resign weeks after the firm reported its renewal of the share buyback program. The firm has tapped a fractional CFO and accounting services provider for the interim.
Khiron Life Sciences last traded at $0.225 on the TSX Venture.
Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.